Oracle Health Sciences Adds 93 Emerging Biopharma Customers

Published on: 

Applied Clinical Trials

Oracle Health Sciences announced that 93 emerging biopharma organizations worldwide have become new customers in the past year. These include sponsors Accera and NewLink Genetics and CROs FMD K&L and 4C Pharma Solutions.

  • FMD K&L adopted Oracle Health Sciences InForm to help ensure data accuracy and efficiencies.

  • Accera, a biotechnology company focused on conditions affecting the central nervous system, uses cloud-based Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service to model scenarios for future trials.

  • 4C Pharma Solutions and NewLink Genetics use Oracle Argus Safety for insight into product-safety issues, improved productivity, and streamlined safety reporting.

Read the full release.